EX-23 17 ex23_1.txt 23.1 John Kinross-Kennedy, C.P.A. 4921 Birch Street, Suite 110 Newport Beach, CA 92660 (949)724-3817 jkinross@zamucen.com -------------------- Mark Scharmann Persident and Chief Executive Officer Immunotechnology Corporation 1661 Lakeview Circle Ogden, Utah 84403 Dear Mr. Scharmann: This is to certify that I consent to the publication of the Form S-4 Registration Statement of Immunotechnology Corporation dated July 24, 2003, an S.E.C. registration statement wherein I expressed audit opinions on financial statements and provided other financial data. /s/ John Kinross-Kennedy --------------------------- John Kinross-Kennedy Certified Public Accountant Cc: John C. Thompson, Esq.